SUN PHARMACEUTICAL INDUSTRIES
Back to Income Statement
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹11,479 Cr | ₹10,929 Cr | ₹9,576 Cr | ₹8,474 Cr | ₹3,273 Cr |
What is the latest Consolidated Net Profit of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹11,479 Cr |
| Mar2025 | ₹10,929 Cr |
| Mar2024 | ₹9,576 Cr |
| Mar2023 | ₹8,474 Cr |
| Mar2022 | ₹3,273 Cr |
How is Consolidated Net Profit of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹11,479 Cr | 5.04 | |
| Mar2025 | ₹10,929 Cr | 14.12 | |
| Mar2024 | ₹9,576 Cr | 13.01 | |
| Mar2023 | ₹8,474 Cr | 158.91 | |
| Mar2022 | ₹3,273 Cr | - | |
Compare Consolidated Net Profit of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,841.3 Cr | -1.4% | -1.3% | 21.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 2.7% | 16.1% | 38.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,109.0 Cr | -1.5% | -3.3% | 35.6% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -0.7% | 1.4% | -2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,328.0 Cr | 3.9% | -1.8% | 0.4% | Stock Analytics | |
| MANKIND PHARMA | ₹99,945.0 Cr | -0.7% | -4.9% | -4.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | -1.4% |
-1.3% |
21.5% |
| SENSEX | -0.6% |
1.1% |
-3.2% |
You may also like the below Video Courses